BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37419619)

  • 41. The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting.
    Goel N; O'Sullivan D; de Wit M; Lindsay CA; Bertheussen H; Latella J; Chau J; MacDonald R; Grieb S; Steinkoenig I; Campbell W
    J Rheumatol Suppl; 2018 Jun; 94():52-53. PubMed ID: 29858356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
    Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
    J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings of the GRAPPA 2022 Executive Retreat.
    Ng BCK; Jadon D; Adebajo A; Ayan G; Duffin KC; Chandran V; Coates LC; D'Agostino MA; de Vlam K; Deodhar A; Eder L; Garg A; Gladman DD; Goel N; Gottlieb AB; Husni ME; Katz A; Kavanaugh A; Lubrano E; Mease PJ; Merola JF; Nash P; Ogdie A; Pennington SR; Perez-Chada LM; Proft F; Rosen CF; Savage L; Goldenstein-Schainberg C; Siebert S; Soriano ER; Steinkoenig I; Tillett W; Armstrong AW; FitzGerald O
    J Rheumatol; 2023 Nov; 50(Suppl 2):71-77. PubMed ID: 37527861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis.
    Torgutalp M; Gladman DD; FitzGerald O; Mease PJ; Poddubnyy D
    J Rheumatol; 2023 Nov; 50(Suppl 2):33-35. PubMed ID: 37419620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases.
    Takeshita J; Chau J; Duffin KC; Goel N
    J Rheumatol; 2022 Jun; 49(6 Suppl 1):48-51. PubMed ID: 35293335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GRAPPA 2020 Research Award Recipients.
    Castillo RL; Yan D; Ashhurst AS; Elliott A; Angioni MM; Scher JU; Naik S; Neimann A; Byrne SN; Payne RJ; FitzGerald O; Pennington SR; Cauli A; Chandran V
    J Rheumatol; 2022 Jun; 49(6 Suppl 1):55-56. PubMed ID: 35293338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations.
    Ritchlin CT; Armstrong A; Johnsson H; Mulder MLM
    J Rheumatol Suppl; 2021 Jun; 97():19-23. PubMed ID: 34074661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis.
    Mease PJ; Nash P; Grieb S; Chandran V
    J Rheumatol; 2023 Nov; 50(Suppl 2):27-30. PubMed ID: 37527863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicians' perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study.
    Sumpton D; Hannan E; Kelly A; Tunnicliffe D; Ming A; Hassett G; Craig JC; Tong A
    Clin Rheumatol; 2021 Apr; 40(4):1369-1380. PubMed ID: 32935247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatments for Psoriatic Arthritis, a Guide for Patients Written by Fellow Patients: A Report from the GRAPPA 2016 Annual Meeting.
    O'Sullivan D; Steinkoenig I; Brooke M
    J Rheumatol; 2017 May; 44(5):686-687. PubMed ID: 28461526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GRAPPA 2017 Project Report.
    Callis Duffin K; FitzGerald O; Kavanaugh A; Mease PJ; Merola JF; Ogdie A; O'Sullivan D; Reddy SM; Ritchlin CT; Coates LC
    J Rheumatol Suppl; 2018 Jun; 94():48-51. PubMed ID: 29858355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting.
    Siebert S; Pennington SR; Raychaudhuri SP; Chaudhari AJ; Jin JQ; Liao W; Chandran V; FitzGerald O
    J Rheumatol; 2023 Nov; 50(Suppl 2):66-70. PubMed ID: 37527860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
    Coates LC; Soriano ER; Corp N; Bertheussen H; Callis Duffin K; Campanholo CB; Chau J; Eder L; Fernández-Ávila DG; FitzGerald O; Garg A; Gladman DD; Goel N; Helliwell PS; Husni ME; Jadon DR; Katz A; Laheru D; Latella J; Leung YY; Lindsay C; Lubrano E; Mazzuoccolo LD; Mease PJ; O'Sullivan D; Ogdie A; Olsder W; Palominos PE; Schick L; Steinkoenig I; de Wit M; van der Windt DA; Kavanaugh A;
    Nat Rev Rheumatol; 2022 Aug; 18(8):465-479. PubMed ID: 35761070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
    Tillett W; McHugh N; Orbai AM; Ogdie A; Leung YY; Coates LC; Mease PJ; Gladman DD; Brooke M; Packham J; O'Sullivan D; FitzGerald O; Helliwell PS
    J Rheumatol Suppl; 2020 Jun; 96():11-18. PubMed ID: 32482762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting.
    Zundell MP; Woodbury MJ; Lee K; Perez-Chada LM; Armstrong AW; Strand V; Merola JF; Gottlieb AB
    J Rheumatol; 2023 Nov; 50(Suppl 2):47-50. PubMed ID: 37453734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
    Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
    Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting.
    Gottlieb AB; Coates LC; van Mens LJJ; Armstrong AW; Merola JF
    J Rheumatol Suppl; 2018 Jun; 94():40-43. PubMed ID: 29858353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.